CRSP reports encouraging fourth-quarter results. The commercial launch of the first CRISPR-based gene therapy, Casgevy, is ...

Vertex Pharmaceuticals (VRTX) stock gets an upgrade from Canaccord Genuity after its Q4 2024 results on Tuesday, Read more here.

BAY RIDGE, Brooklyn (PIX11) — One person has died and two more were injured during a fatal fire in Bay Ridge early Sunday ...

Barclays raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $467 from $435 and keeps an Equal Weight rating on the shares. The ...

Barclays analyst Gena Wang maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price target of $467.00.

The drugmaker is looking to its acute pain drug, Journavx, to drive growth beyond its established line of cystic fibrosis ...

A specially curated, four-course meal will be on the menu this Valentine’s Day at The Abbey Resort. On Friday, Feb. 14, the ...

A groundbreaking sickle cell disease treatment has been approved for use in the UK's National Health Service (NHS). The treatment offers patients with severe forms of the condition hope for a ...

Taking place on Saturday 8 March, 2025 at Lindley Hall in London, British Watchmakers’ Day is a key event in the horological calendar, where visitors will experience a selection of new watches from ...

Financial writer recommends Crispr Therapeutics AG as a strong buy due to cash position, drug pipeline, and promising ...

Welbee, a multi-award-winning provider of survey solutions that support schools and trusts in gathering stakeholder feedback and managing their data efficiently ...

Major indices closed higher on Tuesday as the effects of the new White House administration’s tariffs on a number of its ...